EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonia Symptoms: A Systematic Review

Elisabetta Indelicato iD, Beatriz Carmona-Hidalgo, Javier Quintero, Juan Darío Ortigoza Escobar, Anne Koy, András Salamon, Pawel Tacik, Laura Muñoz-Delgado, Giulia Giannini iD, Martin Reich, Alberto Albanese, Tobias Bäumer und 14 weitere

European Journal of Neurology · 2026-01 · 33 (1)

DOI: 10.1111/ene.70490 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Neurology, online erschienen am 16.01.2026. Verfasst von Elisabetta Indelicato und 25 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rare Movement Disorders Innsbruck, Medical University Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Dystonic Disorders, Dystonia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Deep brain stimulation (DBS) is an essential treatment option for disabling segmental or generalized dystonia. An underlying monogenic etiology is increasingly recognized as an important predictor of DBS outcomes. Moreover, the genetic background of dystonia is continuously expanding, posing new challenges in the tailored counseling of patients regarding advanced therapies.

Methods

To improve the quality of available evidence on the efficacy of DBS for treating monogenic dystonia, we conducted a systematic review in accordance with PRISMA guidelines. We applied a rigorous methodology and maximized the amount of information provided by including all patients, regardless of age or applied rating scale.

Results

Our findings confirm the high probability of a good DBS outcome in patients harboring TOR1A, SGCE, PANK2 , and TAF1 variants. An intermediate response was associated with KMT2B and THAP1 variants. A particularly favorable outcome with > 80% improvement in dystonia symptoms was associated with a subset of DYT‐ TOR1A patients and few cases with SGCE‐, KMT2B‐, THAP1 ‐, GNAO1 ‐, and TAF1 ‐related disease. Poor study quality, non‐systematic assessment of DBS response, and pooling of patients with different genetic etiologies were among the encountered limitations.

Conclusions

Based on the collected evidence, we formulated recommendations for applying DBS in monogenic dystonia. Our findings, together with the cumulative literature, advocate the introduction of genetic testing in the pre‐DBS work‐up. They furthermore highlight the need to implement and report on systematic assessments of DBS outcomes, including mandatory patient‐reported outcomes. These steps will ensure optimal counseling and continuous improvement in the care of patients with monogenic dystonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationDystonic DisordersDystoniaHumansTreatment OutcomeMolecular Chaperones

Stichwörter der Autor:innen

deep brain stimulationdystoniadystonia genesgenetic testingsystematic review

Substanzen

TOR1A protein, humanMolecular Chaperones

Autor:innen und Institutionen

  • Center for Rare Movement Disorders Innsbruck, Medical University Innsbruck, Innsbruck, Austria.
  • Health Technology Assessment Area-AETSA, Andalusian Public Foundation for Progress and Health ("Fundación Progreso y Salud"-"FPS"), Seville, Spain.
  • Movement Disorders Unit, Pediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
  • U-703 Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain.
  • Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

ORCID-Profile: Elisabetta Indelicato, Giulia Giannini, Robert Jech

Förderung

  • European Commission

Zitieren

APA

Indelicato, E., Carmona-Hidalgo, B., Quintero, J., Escobar, J. D. O., Koy, A., Salamon, A., Tacik, P., Muñoz-Delgado, L., Giannini, G., Reich, M., Albanese, A., Bäumer, T., Grandas, F., Jech, R., Leonardos, A., Mir, P., Pérez-Dueñas, B., Perez-Sanchez, J. R., Valldeoriola, F., …, & European Reference Network for Rare Neurological Diseases (ERN‐RND) (2026). Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonia Symptoms: A Systematic Review. European Journal of Neurology, 33(1). https://doi.org/10.1111/ene.70490

Vancouver

Indelicato E, Carmona-Hidalgo B, Quintero J, Escobar JDO, Koy A, Salamon A, et al. Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonia Symptoms: A Systematic Review. European Journal of Neurology. 2026;33(1). doi:10.1111/ene.70490

BibTeX
@article{Indelicato2026,
  author = {Indelicato, Elisabetta and Carmona-Hidalgo, Beatriz and Quintero, Javier and Escobar, Juan Darío Ortigoza and Koy, Anne and Salamon, András and Tacik, Pawel and Muñoz-Delgado, Laura and Giannini, Giulia and Reich, Martin and Albanese, Alberto and Bäumer, Tobias and Grandas, Francisco and Jech, Robert and Leonardos, Athanasios and Mir, Pablo and Pérez-Dueñas, Belén and Perez-Sanchez, Javier Ricardo and Valldeoriola, Francesc and Zanni, Ginevra and Vidailhet, Marie and Rodríguez-López, Rocío and Blasco-Amaro, Juan Antonio and Reinhard, Carola and Boesch, Sylvia and European Reference Network for Rare Neurological Diseases (ERN‐RND), European Reference Network for Rare Neurological Diseases (ERN‐RND)},
  title = {Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonia Symptoms: A Systematic Review},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {1},
  doi = {10.1111/ene.70490}
}
Kostenlos starten →